Back to results
US 11,617,750 B2Granted
Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
AssigneeAcetylon Pharmaceuticals, Inc.
InventorsJohn H. van Duzer, Ralph Mazitschek, Walter Ogier, James E. Bradner, Guoxiang Huang, Dejian Xie, Nan Yu
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel “reverse amide” compounds comprising a zinc chelator group, and the use of such compounds in the inhibition of HDAC6 and in the treatment of various diseases, disorders or conditions related to HDAC6.
Claims13
A compound of formula I:
- or a pharmaceutically acceptable salt, ester or prodrug thereof,
- wherein,
- Z is N;
- ring A is phenyl, pyridinyl, pyrazinyl, indolyl, imidazolyl, oxazolyl, furyl, thienyl, thiazolyl, triazolyl, isoxazolyl, quinolinyl, pyrrolyl, pyrazolyl, or 5,6,7,8-tetrahydroisoquinoline;
- all of which may be optionally substituted with halo;
- ring B is aryl or heteroaryl;
- wherein aryl or heteroaryl may be optionally substituted with alkyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, aralkyl, haloalkyl, halo, OH, NH2, NHR″, CN, or NO2;
- R1 is H, alkyl, haloalkyl, alkenyl, aryl, arylalkyl, heteroaryl, heterocyclic, or carbocyclic, wherein aryl and heteroaryl may be optionally substituted with OH or halo;
- R is H or alkyl;
- R″ is H or C1-12 alkyl;
- and
- n is 4, 5, 6, 7, or 8.
9 more elements
A compound selected from the group consisting of:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.